Pathogenesis and pathophysiology of aortic valve stenosis in adults

Polskie Archiwum Medycyny Wewnetrznej

Volumn 121, Issue 11, 2011, Pages 409-413

  Olszowska, Maria ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Calcific aortic stenosis; Valvular heart disease

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; MATRIX METALLOPROTEINASE; VASCULOTROPIN;

AGING; ANGIOGENESIS; AORTA VALVE STENOSIS; ATHEROSCLEROSIS; BICUSPID AORTIC VALVE; CALCIFICATION; CARDIOVASCULAR RISK; CELL PROLIFERATION; DEGENERATIVE DISEASE; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; LIPID STORAGE; OSSIFICATION; OXIDATIVE STRESS; REVIEW; RHEUMATIC HEART DISEASE; TRICUSPID VALVE DISEASE;

EID: 83055171417     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1103     Document Type: Review

References (39)

1. Bernard Iunga, Gabriel Baronb, Eric G, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease Eur Heart J. 2003; 24: 1231-1243.
2. Rajamannan NM, Evans FJ, Aikawa E, et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the national heart and lung and blood institute aortic stenosis working group executive summary: calcific aortic valve disease - 2011 update. Circulation. 2011; 124: 1783-1791.
3. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005; 111: 3316-3326. (Pubitemid 40875006)
4. Yetkin E, Waltenberger J. Molecular and cellular mechanisms of aortic stenosis. Int J Cardiol. 2009; 135: 4-13.
5. Kaden JJ, Dempfle CE, Grobholz R, et al. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis. 2003; 170: 205-211. (Pubitemid 37377791)
6. Helske S, Kupari M, Lindstedt KA, Kovanen PT. Aortic valve stenosis: an active atheroinflammatory process. Curr Opin Lipidol. 2007; 18: 483-491. (Pubitemid 47462199)
7. Rajamannan NM. Calcific aortic stenosis: lessons learned from experimental and clinical studies. Arterioscler Thromb Vasc Biol. 2009; 29: 162-168.
8. Akat K, Borggrefe M, Kaden JJ. Aortic valve calcification: basic science to clinical practice. Heart. 2009; 95: 616-623.
9. Miller JD, Weiss RM, Heistad DD. Calcific aortic valve stenosis: methods, models, and mechanisms. Circ Res. 2011; 108: 1392-1412.
10. Kaden JJ, Kiliç R, Sarikoç A, et al. Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification. Int J Mol Med. 2005; 16: 869-872.
11. Winchester R, Wiesendanger M, O'Brien W, et al. Circulating activated and effector memory T cells are associated with calcification and clonal expansions in bicuspid and tricuspid valves of calcific aortic stenosis. J Immunol. 2011; 187: 1006-1014.
12. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol. 2007; 171: 1407-1418. (Pubitemid 350158303)
13. Poggio P, Grau JB, Field BC, et al. Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with Calcific Aortic Stenosis and controls. J Cell Physiol. 2010 Dec 6. [Epub ahead of print].
14. Kaden JJ, Bickelhaupt S, Grobholz R, et al. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. J Heart Valve Dis. 2004; 13: 560-566.
15. Chen JH, Simmons CA. Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues. Circ Res. 2011; 108: 1510-1524.
16. Yu PJ, Skolnick A, Ferrari G, et al. Correlation between plasma osteopontin levels and aortic valve calcification: potential insights into the pathogenesis of aortic valve calcification and stenosis. J Thorac Cardiovasc Surg. 2009; 138: 196-199.
17. Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA. 2004; 92: 490-495. (Pubitemid 38988958)
18. Lee NK, Choi YG, Baik JY, et al. A crucial role for reactive oxygen species in rankl-induced osteoclast differentiation. Blood. 2005; 106: 852-859. (Pubitemid 41076424)
19. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997; 18: 4-25. (Pubitemid 27076453)
20. Waltenberger J. Modulation of growth factor action: implications for the treatment of cardiovascular diseases. Circulation. 1997; 96: 4083-4094.
21. Chen JH, Chen WL, Sider KL, et al. β-catenin mediates mechanically regulated, transforming growth factor-β1-induced myofibroblast differentiation of aortic valve interstitial cells. Arterioscler Thromb Vasc Biol. 2011; 31: 590-597.
22. Jian B, Narula N, Li QY, et al. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg. 2003; 75: 457-465. (Pubitemid 36184488)
23. Soini Y, Salo T, Satta J. Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis. Hum Pathol. 2003; 34: 756-763. (Pubitemid 37040610)
24. Satta J, Oiva J, Salo T, et al. Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis. Ann Thorac Surg. 2003; 76: 681-688. (Pubitemid 37100721)
25. Kaden JJ, Dempfle CE, Grobholz R, et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol. 2005; 14: 80-87. (Pubitemid 40381303)
26. Helske S, Lindstedt KA, Laine M, et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J Am Coll Cardiol. 2004; 44: 1859-1866. (Pubitemid 39424087)
27. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin- converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004; 110: 1291-1295. (Pubitemid 39202347)
28. Cagirci G, Cay S, Karakurt O, et al. Paraoxonase activity might be predictive of the severity of aortic valve stenosis. J Heart Valve Dis. 2010; 19: 453-458.
29. Rajamannan NM. Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation. Cardiovasc Pathol. 2011; 20: 168-176.
30. Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005; 437: 270-274. (Pubitemid 41294491)
31. Novaro GM, Sachar R, Pearce GL, et al. Association between apolipoprotein E alleles and calcific valvular heart disease. Circulation. 2003; 108: 1804-1808. (Pubitemid 37296088)
32. Ortlepp JR, Hoffmann R, Ohme F, et al. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart. 2001; 85: 635-638. (Pubitemid 32973456)
33. Singh R, Strom JA, Ondrovic L, et al. Age-related changes in the aortic valve affect leaflet stress distributions: implications for aortic valve degeneration. J Heart Valve Dis. 2008; 17: 290-298.
34. Matsumoto Y, Adams V, Walther C, et al. Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair. Eur Heart J. 2009; 30: 346-355.
35. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease. The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268. (Pubitemid 46276943)
36. Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009; 373: 956-966.
37. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis EAE/ASE recommendations of clinical practice. J Am Soc Echocardiogr. 2009; 22: 1-23.
38. Islam S, Islam E, Cevik C, et al. Aortic stenosis and angiodysplastic gastrointestinal bleeding: Heyde's disease. Heart Lung. 2011 Oct 11. [Epub ahead of print].
39. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired vonWillebrand syndrome in aortic stenosis. N Engl J Med. 2003; 349: 343-349. (Pubitemid 36886240)